Sign in

NCT07160751Recruiting

Cognition and Patients With Lung Cancer

Observation of Cognitive Complaints in Patients With Localized, Operable Non-small Cell Lung Cancer

Source: ClinicalTrials.gov · Last updated 22 Oct 2026

Brief summary (registry, in English)

Cognitive complaints in patients treated for cancer can impact their quality of life. Studies show that these cognitive complaints may have multifactorial origins and appear at different stages of the care pathway. In a population of patients treated for confirmed localized non-small cell lung cancer (NSCLC), this study aims to detect and monitor the onset of cognitive complaints over time. The timing of the complaints during the treatment, the cognitive functions affected (memory, attention, concentration…), as well as the perceived intensity of the discomfort, will be examined. The study also explores the influence of co-factors such as mood, fatigue, socio-cultural status, and level of social vulnerability on these cognitive complaints.

Status (registry)
Recruiting
Study type
Observational
Enrollment
90 (estimated)
First submitted
29 Aug 2025
Start date
24 Apr 2026
Primary completion date
31 Jan 2028
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Diseases
Lung cancer
NCT number
NCT07160751

What you commit to

  • Study type: Observational
  • Planned participants: 90
  • From 24 Apr 2026 to the primary completion date, 31 Jan 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Known pre-existing cognitive disorders
  • Presence on the day of inclusion of one or more factors causing mental confusion: electrolyte imbalances, renal failure, hepatic failure, infections, bladder distension, fecal impaction
  • Known psychiatric or neurological diseases (e.g., multiple sclerosis, Parkinson's disease, dementia, stroke, traumatic brain injury with loss of consciousness)
  • History of cancer treatment within the past 10 years

Other

  • Current use of neuroleptic treatments
  • Fibromyalgia
  • Individuals who cannot read French or are not French-speaking
  • Patients who have never attended school

Who the study is looking for

  • Adult patient aged 18 to 74 years
  • Suspected or confirmed localized and operable non-small cell lung cancer (NSCLC)
  • Surgical treatment with or without perioperative systemic medical therapy
  • Ability to independently complete self-questionnaires via the Cleanweb platform
  • Patients with access to a phone, tablet, or computer at home to complete the electronic self-questionnaires.

Age in the registry: 18 years to 74 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hôpital Cochin - Service de pneumologie
Coordinator of this site? Confirm its status
ParisFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.